Ordering Recommendation

Use to quantify and characterize plasma cells in patient with previously established diagnosis of plasma cell dyscrasia. If there is clinical concern for other hematologic malignancies, order Leukemia /Lymphoma Phenotyping Evaluation by Flow Cytometry (3001780).

New York DOH Approval Status

This test is not New York state approved. There are no New York state-approved laboratories available. The performing laboratory will submit an NYSDOH Single Use Permit (SUP) upon receipt of order. If SUP is approved by NYSDOH, testing will be performed.

Specimen Required

Patient Preparation
Collect

Bone marrow aspirate in green (sodium heparin) or lavender (EDTA).

Specimen Preparation

Transport 5 mL bone marrow aspirate. (Min: 1 mL) Do not freeze.

Storage/Transport Temperature

Room temperature. Also acceptable: Refrigerated. Specimen should be received within 24 hours of collection for optimal cell viability.

Unacceptable Conditions

Frozen specimens. Paraffin-embedded specimens. Clotted specimens.

Remarks
Stability

Ambient: 48 hours; Refrigerated: 48 hours; Frozen: Unacceptable

Methodology

Flow Cytometry

Performed

Sun-Sat

Reported

1-3 days

Reference Interval

Interpretive Data

Refer to report.

Compliance Category

Laboratory Developed Test (LDT)

Note

Hotline History

N/A

CPT Codes

88184; 88185 x17; 88189

Components

Component Test Code* Component Chart Name LOINC
3002083 MM MRD Interpretation 48767-8
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Multiple Myeloma
  • Multiple Myeloma MRD
  • Plasma Cell MRD, myeloma MRD
CLARISPECT(TM) Multiple Myeloma MRD by Spectral Flow Cytometry